A detailed history of C M Bidwell & Associates LTD transactions in Invitae Corp stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 112 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112
Previous 931 87.97%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.01 - $0.61 $8 - $499
-819 Reduced 87.97%
112 $0
Q4 2022

Feb 10, 2023

BUY
$1.71 - $3.61 $1,592 - $3,360
931 New
931 $1,000
Q2 2022

Aug 12, 2022

SELL
$2.13 - $9.01 $238 - $1,009
-112 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$6.28 - $15.59 $703 - $1,746
112 New
112 $1,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.